Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Svetlana V. Khokhlova"'
Autor:
Olga B. Ladodo, Mariia V. Iurova, Svetlana V. Khokhlova, Valerii V. Rodionov, Elena L. Sheshko, Viktor V. Zubkov, Mziya I. Makieva, Dar’ia A. Chutkova, Elena S. Akhapkina, Dmitriy N. Degtyarev
Publikováno v:
Современная онкология, Vol 26, Iss 1, Pp 73-79 (2024)
In the modern world breastfeeding (BF) is considered as a significant factor in reducing the risk of developing malignant tumors of the mammary gland and ovaries. However, the problem of maintenance or refusing BF in malignant neoplasms (malignant ne
Externí odkaz:
https://doaj.org/article/f7cf5b48c19348ae862d9cc01640400a
Autor:
Dmitriy A. Morozov, Irina V. Kolyadina, Irina V. Poddubnaya, Inna P. Ganshina, Svetlana V. Khokhlova, Vlada V. Kоmetova, Valery V. Rodionov
Publikováno v:
Современная онкология, Vol 23, Iss 4, Pp 603-609 (2021)
Background. Neoadjuvant chemotherapy (NACT) with dual anti-HER2 blockade has become a priority in the treatment of patients with HER2+ breast cancer (BC) stages IIIII. However, the question of the accordance of various systems for assessing tumor res
Externí odkaz:
https://doaj.org/article/e65ca88a99b94fd58035886dda671788
Autor:
Irina V. Kolyadina, Tatiana Yu. Danzanova, Svetlana V. Khokhlova, Oksana P. Trofimova, Ekaterina V. Kovaleva, Valerii V. Rodionov, Irina V. Poddubnaya
Publikováno v:
Современная онкология, Vol 22, Iss 1, Pp 46-52 (2020)
The involvement of axillary lymph nodes is one of the most important prognostic factors, significantly affecting the treatment strategy for early breast cancer (BC). The risk of axillary lymph node metastases depends directly on a number of factors (
Externí odkaz:
https://doaj.org/article/e0d0f965dba7427899ab6e589e1caaa9
Autor:
Marina S. Gubenko, Vitaliy I. Loginov, Aleksey M. Burdennyy, Irina V. Pronina, Svetlana V. Khokhlova, Sergey S. Pertsov
Publikováno v:
I.P. Pavlov Russian Medical Biological Herald. 30:123-132
INTRODUCTION: Lung cancer is the most common malignant neoplasm. Despite advances in target therapy, immunotherapy, and chemotherapy, non-small cell lung cancer remains the major cause of cancer-related death worldwide. Tumor development is a complex
Autor:
Svetlana V. Khokhlova, Ulia G. Payanidi, Kirill I. Zhordania, Ulia E. Dobrokhotova, Aleksei S. Shevchuk
Publikováno v:
Онкогинекология. :20-27
Autor:
Svetlana V. Khokhlova, Leila V. Adamyan, Kozachenko Vp, Kirill I. Zhordania, Ulia G. Payanidi
Publikováno v:
Онкогинекология. :48-53
Autor:
Irina V Kolyadina, Irina S Bulavina, Vladislav V Petkau, Natalia V Strakhova, Vera A Gorbunova, Elena I Kovalenko, Liudmila V Manziuk, Elena V Artamonova, Liudmila G Zhukova, Larisa V Bolotina, Inna P Gan'shina, Tatiana Iu Semiglazova, Aleksei G Manikhas, Natalia A Raevskaia, Ilia M Itkin, Svetlana V Khokhlova, Dmitrii V Filonenko, Viktor E Gol'dberg, Natalia O Popova, Dmitrii M Ponomarenko, Valentina E Shikina, Liubov I Vladimirova, Natalia M Tikhanovskaia, Elena V Karabina, Guzel Z Mukhametshina, Alfiia I Khasanova, Sufiia Z Safina, Mikhail V Shaidorov, Andrei E Orlov, Iuliia V Kostalanova, Natalia V Levchenko, Mikhail A Osipov, Tatiana V Karandeeva, Irina V Evstigneeva, Igor S Chernov, Dzheims Dzh Kolokolov, Anton Iu Povyshev, Alina S Shatokhina, Elena M Cherniakova, Oksana N Shkodenko, Evgeniia S Kuz'mina
Publikováno v:
Современная онкология, Vol 21, Iss 2, Pp 17-24 (2019)
Aim. Eribulin is an active cytostatic, associated with a wide range of mechanisms of antitumor effects, but eribulin efficiency and safety in patients with breast cancer (BC), associated with cerebral metastases are still poorly understood. Materials
Externí odkaz:
https://doaj.org/article/5f21fe71ca7c49f6a857b2579dfadccd